Product Code: ARZ220931
The global biocatalysts market is expected to grow at a CAGR of 5.60% during 2021-2027.
MARKET SYNOPSIS
Biocatalysts are substances, specifically enzymes, that activate or speed up a biochemical reaction. Biocatalysts are used in chemical synthesis in various industries (such as pharmaceuticals, food & beverages, animal nutrition, household, and others). In the pharmaceutical industry, biocatalysts help in manufacturing drugs for DNA/RNA treatment, cancer, heart-related disease, and other treatments.
Increasing demand for biobased products drives the biocatalysts market. Due to emerging technology, sustainability is growing all over the world. In the pharmaceutical industry, companies have started using biobased drugs to improve the quality of products, making the pharmaceutical biocatalysts market grow rapidly. Thus, top companies follow the expansion strategy for acquiring a greater biocatalysts market share. The food & beverages industry is rising due to the increasing consumption of food & beverages, thus increasing the demand for biocatalysts in the global industry.
MARKET TRENDS & DRIVERS
Increase in Food Consumption Due to Growth in Population
- The food industry includes four major sectors - producers, marketers, processors, and farm services. During the Covid 19, the demand for food supplies increased, resulting in the food industry's growth. Enzymes are used in the food industry as a preservative, the best substitute for chemical preservatives. They improve the quality of products such as starch, fruit juices, cheese, animal feed, and beer & wine. From the application perspective, the demand for animal feed is increasing due to higher poultry, meat, and dairy consumption.
Increasing Demand from Pharmaceutical Industry
- The pharmaceutical industry's revenue is increasing yearly due to increasing demand for the drugs used for manufacturing pharmaceutical products. In past years, the Chinese pharma industry has been on the top in terms of growth rate. The consumption of pharmaceutical products is growing due to changes in clinical practices and increasing chronic and aging-related issues.
- The lowering of regulatory barriers for new drugs in the US causes an increased demand for pharma sector products globally. During the Covid-19 pandemic, the highest demand for pharmaceutical products was observed. The demand for new drugs is still high owing to the recurrence of new variants of Covid-19 in various countries. The demand for pharmaceutical products is also increasing in developing countries such as India, China, and Brazil, among others owing to the emergence of Covid-19 variants, lifestyle diseases, and an aging population. Biocatalysts are used in the manufacturing processes of antibiotics to treat such diseases. And with a growing global pharmaceutical industry, the biocatalysts market is also growing.
MARKET RESTRAINT
Technical Barriers Affecting Industry
- Biocatalysis is a process that accelerates the chemical process by using biomolecules. It includes mild reaction and high selectivity conditions. Therefore, biocatalysts play an important role in the chemical industry and are gaining relevance in industrial applications. But, there is difficulty in finding the accurate protein structure of biocatalysts. The process is time-consuming and requires more catalysts to fulfilling the chemical reaction process. For the biocatalysts manufacturing process, specific conditions such as new substrate, new concentration, and other conditions are required which are not found easily in nature. Thus, increasing the cost of producing the biocatalysts.
SEGMENTATION ANALYSIS
INSIGHTS BY TYPE
- Carbohydrases is the largest segment by type in the global biocatalysts market and is expected to reach USD 231.03 million by 2027. Carbohydrases are mainly used in the food industry as biocatalysts. Most of these biocatalysts used in the food industry are produced from fungi, yeast, and bacteria. Carbohydrases are used in milk products as digestion agents to reduce milk lactose. These are further classified into alpha, beta amylases, cellulases, glucosidase, pectinases, mannanases, galacto, and pullulanase.
- The global proteases-based biocatalysts market was valued at USD 134.40 million in 2021 and is the second largest industry by type segment. The proteases are used in the cleaning, leather, and dairy industries. Based on the catalysis mechanism, the proteases are classified into further classes glutamic, aspartic, metalloproteases, threonine, cysteine, and serine proteases which activate the water molecule and attack the proteins.
- Lipases are used in the catalysis of fats, which helps reduce their food content. These are derived from animal and plant enzymes used in various biological processes, which are used for inflammation, diet, and increasing metabolism. The lipases segment is expected to grow at a CAGR of 5.49% during the forecast period. These are used in esters and have high scope in biofuels. The increased demand for biofuels is due to the increasing prices of crude oil, which further increases the demand for lipases in the biocatalysts markets.
Segmentation by Type
- Carbohydrases
- Proteases
- Polymerases & Nucleases
- Lipases
- Phytases
- Other
INSIGHTS BY END-USE
- The global biocatalysts market by end-use is categorized as pharmaceutical, food & beverages, animal nutrition, household, and others. The pharmaceutical is the largest segment by end-use and is expected to cross USD 215.42 million by 2027. Due to growth in the global population, the demand for pharmaceutical products is increasing. Due to which people are becoming more health conscious, pharmaceutical companies are focusing on increasing the bio-based content in drug formulations. In the pharmaceutical industry, biocatalysts are used for molecular biology, extraction of medically important compounds, diagnostic procedures, chemical pharmaceutical manufacturing, and deficiencies supplements.
- The food & beverages segment is growing with a CAGR of 6.31 % during the forecast period and is the second largest segment by end-use. Biocatalysts have been used for hundreds of years in the food & beverages industry. Commercial biocatalysts are produced from microbial, plants, and animals. There is a massive demand for bakery biocatalysts in the industry for extending shelf life, mainly in Europe and North America. Biocatalyst manufacturing companies are developing new designs to improve bakery food quality.
Segmentation by End Use
- Pharmaceutical
- Food & Beverages
- Animal Nutrition
- Household
- Others
GEOGRAPHICAL ANALYSIS
North America dominates the global biocatalysts market and is expected to grow at a CAGR of 6.27% during the forecast period. The region is the leading market for biocatalysts because of its rapidly developing infrastructure, readily increasing population, and growing demand from various industries such as food & beverage, pharmaceutical, animal nutrition, and household. The US and Canada are the two major countries dominating North America's biocatalyst market. The demand for biocatalysts in North America's pharmaceutical industry is increasing with the rise in pharma products and the presence of the world-leading ten pharmaceutical companies in the US.
APAC biocatalysts market is the second largest industry globally and is expected to grow the highest CAGR during the forecast period. With the changing technology & innovations in food & beverages, the demand for biocatalysts is increasing. Increasing health expenditure, increasing health consciousness, increasing new diseases, and others are the key factors for the growing pharmaceutical market, further contributing to the Asia Pacific industry.
Germany, Italy, France, and Spain are the major countries in the European biocatalyst market. The increasing consumption of biocatalysts is attributed to the rising per capita income in European countries. High spending on healthy food, attributed to people's health-conscious habits, and growing demand for food & beverages biocatalysts are significant market drivers in Europe.
Segmentation by Geography
- APAC
- China
- India
- Japan
- South Korea
- Rest of APAC
- North America
- Europe
- Germany
- Spain
- France
- Italy
- Rest of Europe
- Latin America
- Brazil
- Mexico
- Rest Of Latin America
- Middle East & Africa
- South Africa
- South Arabia
- Rest of the Middle East & Africa
VENDOR LANDSCAPE
Some key players in the global biocatalysts market include DuPont (U.S.), AB Enzymes (Germany), BASF SE (Germany), Novozymes (Denmark), and DSM (Netherlands). These players have adopted strategies such as expansion, acquisitions, new product development, joint ventures, and others to increase their revenues in the biocatalysts market. Furthermore, other prominent companies such as Amano Enzymes (Japan), Dyadic International (U.S.), Codexis (U.S.), and others have invested considerable capital in R&D to develop biocatalysts-based products that will appeal to the customers. Therefore, these other prominent companies are giving tough competition to major companies.
The major companies follow a merger and acquisition strategy, giving them a competitive advantage to boost their market share. The key vendors have undertaken various strategies to grow in the global biocatalysts market. The growth in sustainable processes and innovations has challenged all companies globally. Investments in R&D, technological advancement, and environmental and economic challenges drive the demand for innovative and sustainable biocatalysts products.
Key Vendors
- DuPont
- BASF SE
- DSM
- AB Enzymes
- Novozymes
Other Prominent Vendors
- Chr Hansen Holding A/S
- Codexis
- Dyadic International Inc.
- Amano Enzymes
- Biocatalysts
- Nature Bioscience Pvt Ltd.
- Johnson Matthey
- Advanced Enzymes Technologies
- Zymtronix, Inc.
- Nutritech
- Hoffmann-La Roche Ltd (Roche CustomBiotech)
- Aumenzymes
- The Soufflet Group
- Iosynth
Key Developments In The Global Biocatalysts Market:
- In 2021 Novozymes bought majority stakes in the Mumbai (India) based Synergia Life Sciences company, a global leader in the microbiome therapeutic and vitamin k2-7 manufacturer and supplier.
- DSM acquired the U.S.-based First Choice Ingredients company, a manufacturer of dairy-based flavorings. This deal gives the company fermentation and biotechnology solutions.
KEY QUESTIONS ANSWERED
- 1. What is the revenue from the global biocatalysts market?
- 2. What is the growth rate of the biocatalysts market?
- 3. Who are the key players in the global biocatalysts market?
- 4. What is the projected biocatalysts market by 2027?
- 5. What are the key driving factors in the global biocatalysts market?
- 6. Which region dominates the global biocatalysts Market?
TABLE OF CONTENTS
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
- 4.1 MARKET DEFINITION
- 4.1.1 INCLUSIONS
- 4.1.2 EXCLUSIONS
- 4.1.3 MARKET ESTIMATION CAVEATS
- 4.2 BASE YEAR
- 4.3 SCOPE OF THE STUDY
- 4.3.1 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
- 5.1 KEY CAVEATS
- 5.2 CURRENCY CONVERSION
- 5.3 MARKET DERIVATION
6 PREMIUM INSIGHTS
- 6.1 INTRODUCTION
- 6.2 MARKET SYNOPSIS
- 6.2.1 ENABLER
- 6.2.2 OPPORTUNITIES
- 6.2.3 RESTRAINT
- 6.3 SEGMENT REVIEW
- 6.3.1 END-USERS
- 6.3.2 TYPE
- 6.4 GEOGRAPHY
- 6.5 COMPANIES AND STRATEGIES
7 MARKET AT A GLANCE
8 INTRODUCTION
- 8.1 OVERVIEW
- 8.2 VALUE CHAIN ANALYSIS
- 8.2.1 RAW MATERIALS
- 8.2.2 BIOCATALYST MANUFACTURER
- 8.2.3 DISTRIBUTOR
- 8.2.4 APPLICATION
- 8.3 MACROECONOMIC FACTORS
- 8.3.1 PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRIES
- 8.3.2 FOOD & BEVERAGES INDUSTRY
9 MARKET OPPORTUNITIES & TRENDS
- 9.1 INCREASING DEMAND FROM PHARMACEUTICAL INDUSTRY
- 9.2 SOARING DEMAND FOR BIOFUEL
- 9.3 ADOPTION OF SUSTAINABILITY STANDARDS TO IMPROVE PRODUCTIVITY & PROFITABILITY
- 9.4 INCREASING USE OF CLEANING PRODUCTS
10 MARKET GROWTH ENABLERS
- 10.1 INCREASE IN FOOD CONSUMPTION DUE TO GROWING POPULATION
- 10.2 RISE IN DEMAND FOR PLANT-BASED PRODUCTS
11 MARKET GROWTH RESTRAINTS
- 11.1 TECHNICAL BARRIERS AFFECTING BIOCATALYSTS MARKET
- 11.2 HIGH COST & LACK OF AWARENESS OF BIOBASED PRODUCTS
12 MARKET LANDSCAPE
- 12.1 MARKET OVERVIEW
- 12.2 MARKET SIZE & FORECAST
- 12.3 FIVE FORCES ANALYSIS
- 12.3.1 THREAT OF NEW ENTRANTS
- 12.3.2 BARGAINING POWER OF SUPPLIERS
- 12.3.3 BARGAINING POWER OF BUYERS
- 12.3.4 THREAT OF SUBSTITUTES
- 12.3.5 COMPETITIVE RIVALRY
13 TYPE
- 13.1 MARKET SNAPSHOT & GROWTH ENGINE
- 13.2 MARKET OVERVIEW
- 13.3 CARBOHYDRASES
- 13.3.1 MARKET OVERVIEW
- 13.3.2 MARKET SIZE & FORECAST
- 13.3.3 MARKET BY GEOGRAPHY
- 13.4 PROTEASES
- 13.4.1 MARKET OVERVIEW
- 13.4.2 MARKET SIZE & FORECAST
- 13.4.3 MARKET BY GEOGRAPHY
- 13.5 POLYMERASES & NUCLEASES
- 13.5.1 MARKET OVERVIEW
- 13.5.2 MARKET SIZE & FORECAST
- 13.5.3 MARKET BY GEOGRAPHY
- 13.6 LIPASES
- 13.6.1 MARKET OVERVIEW
- 13.6.2 MARKET SIZE & FORECAST
- 13.6.3 MARKET BY GEOGRAPHY
- 13.7 PHYTASES
- 13.7.1 MARKET OVERVIEW
- 13.7.2 MARKET SIZE & FORECAST
- 13.7.3 MARKET BY GEOGRAPHY
- 13.8 OTHERS
- 13.8.1 MARKET OVERVIEW
- 13.8.2 MARKET SIZE & FORECAST
- 13.8.3 MARKET BY GEOGRAPHY
14 END-USER
- 14.1 MARKET SNAPSHOT & GROWTH ENGINE
- 14.2 MARKET OVERVIEW
- 14.3 PHARMACEUTICAL
- 14.3.1 MARKET OVERVIEW
- 14.3.2 MARKET SIZE & FORECAST
- 14.3.3 MARKET BY GEOGRAPHY
- 14.4 FOOD & BEVERAGES
- 14.4.1 MARKET OVERVIEW
- 14.4.2 MARKET SIZE & FORECAST
- 14.4.3 MARKET BY GEOGRAPHY
- 14.5 ANIMAL NUTRITION
- 14.5.1 MARKET OVERVIEW
- 14.5.2 MARKET SIZE & FORECAST
- 14.5.3 MARKET BY GEOGRAPHY
- 14.6 HOUSEHOLD
- 14.6.1 MARKET OVERVIEW
- 14.6.2 MARKET SIZE & FORECAST
- 14.6.3 MARKET BY GEOGRAPHY
- 14.7 OTHERS
- 14.7.1 MARKET OVERVIEW
- 14.7.2 MARKET SIZE & FORECAST
- 14.7.3 MARKET BY GEOGRAPHY
15 GEOGRAPHY
- 15.1 MARKET SNAPSHOT & GROWTH ENGINE
- 15.2 GEOGRAPHIC OVERVIEW
16 NORTH AMERICA
- 16.1 MARKET OVERVIEW
- 16.2 MARKET SIZE & FORECAST
- 16.3 TYPE
- 16.3.1 MARKET SIZE & FORECAST
- 16.4 END-USER
- 16.4.1 MARKET SIZE & FORECAST
- 16.5 KEY COUNTRIES
- 16.6 US
- 16.6.1 MARKET SIZE & FORECAST
- 16.7 CANADA
- 16.7.1 MARKET SIZE & FORECAST
17 EUROPE
- 17.1 MARKET OVERVIEW
- 17.2 MARKET SIZE & FORECAST
- 17.3 TYPE
- 17.3.1 MARKET SIZE & FORECAST
- 17.4 END-USER
- 17.4.1 MARKET SIZE & FORECAST
- 17.5 KEY COUNTRIES
- 17.6 GERMANY
- 17.6.1 MARKET SIZE & FORECAST
- 17.7 FRANCE
- 17.7.1 MARKET SIZE & FORECAST
- 17.8 ITALY
- 17.8.1 MARKET SIZE & FORECAST
- 17.9 SPAIN
- 17.9.1 MARKET SIZE & FORECAST
- 17.10 REST OF EUROPE
- 17.10.1 MARKET SIZE & FORECAST
18 APAC
- 18.1 MARKET OVERVIEW
- 18.2 MARKET SIZE & FORECAST
- 18.3 TYPE
- 18.3.1 MARKET SIZE & FORECAST
- 18.4 END-USER
- 18.4.1 MARKET SIZE & FORECAST
- 18.5 KEY COUNTRIES
- 18.6 CHINA
- 18.6.1 MARKET SIZE & FORECAST
- 18.7 INDIA
- 18.7.1 MARKET SIZE & FORECAST
- 18.8 JAPAN
- 18.8.1 MARKET SIZE & FORECAST
- 18.9 SOUTH KOREA
- 18.9.1 MARKET SIZE & FORECAST
- 18.10 REST OF APAC
- 18.10.1 MARKET SIZE & FORECAST
19 MIDDLE EAST & AFRICA
- 19.1 MARKET OVERVIEW
- 19.2 MARKET SIZE & FORECAST
- 19.3 TYPE
- 19.3.1 MARKET SIZE & FORECAST
- 19.4 END-USER
- 19.4.1 MARKET SIZE & FORECAST
- 19.5 KEY COUNTRIES
- 19.6 SAUDI ARABIA
- 19.6.1 MARKET SIZE & FORECAST
- 19.7 SOUTH AFRICA
- 19.7.1 MARKET SIZE & FORECAST
- 19.8 REST OF MIDDLE EAST & AFRICA
- 19.8.1 MARKET SIZE & FORECAST
20 LATIN AMERICA
- 20.1 MARKET OVERVIEW
- 20.2 MARKET SIZE & FORECAST
- 20.3 TYPE
- 20.3.1 MARKET SIZE & FORECAST
- 20.4 END-USER
- 20.4.1 MARKET SIZE & FORECAST
- 20.5 KEY COUNTRIES
- 20.6 BRAZIL
- 20.6.1 MARKET SIZE & FORECAST
- 20.7 MEXICO
- 20.7.1 MARKET SIZE & FORECAST
- 20.8 REST OF LATIN AMERICA
- 20.8.1 MARKET SIZE & FORECAST
21 COMPETITIVE LANDSCAPE
- 21.1 COMPETITION OVERVIEW
22 KEY COMPANY PROFILES
- 22.1 DUPONT
- 22.1.1 BUSINESS OVERVIEW
- 22.1.2 FINANCIAL OVERVIEW
- 22.1.3 PRODUCT OFFERINGS
- 22.1.4 KEY STRATEGIES
- 22.1.5 KEY STRENGTHS
- 22.1.6 KEY OPPORTUNITIES
- 22.2 BASF SE
- 22.2.1 BUSINESS OVERVIEW
- 22.2.2 FINANCIAL OVERVIEW
- 22.2.3 PRODUCT OFFERINGS
- 22.2.4 KEY STRATEGIES
- 22.2.5 KEY STRENGTHS
- 22.2.6 KEY OPPORTUNITY
- 22.3 DSM
- 22.3.1 BUSINESS OVERVIEW
- 22.3.2 FINANCIAL OVERVIEW
- 22.3.3 PRODUCT OFFERINGS
- 22.3.4 KEY STRATEGY
- 22.3.5 KEY STRENGTHS
- 22.3.6 KEY OPPORTUNITY
- 22.4 AB ENZYMES
- 22.4.1 BUSINESS OVERVIEW
- 22.4.2 FINANCIAL OVERVIEW
- 22.4.3 PRODUCT OFFERINGS
- 22.4.4 KEY STRATEGIES
- 22.4.5 KEY STRENGTHS
- 22.4.6 KEY OPPORTUNITIES
- 22.5 NOVOZYMES
- 22.5.1 BUSINESS OVERVIEW
- 22.5.2 FINANCIAL OVERVIEW
- 22.5.3 PRODUCT OFFERINGS
- 22.5.4 KEY STRATEGIES
- 22.5.5 KEY STRENGTHS
- 22.5.6 KEY OPPORTUNITIES
23 OTHER PROMINENT VENDORS
- 23.1 CHR. HANSEN HOLDING A/S
- 23.1.1 COMPANY OVERVIEW
- 23.1.2 BUSINESS OVERVIEW
- 23.1.3 PRODUCT OFFERINGS
- 23.2 CODEXIS
- 23.2.1 COMPANY OVERVIEW
- 23.2.2 BUSINESS OVERVIEW
- 23.2.3 PRODUCT OFFERINGS
- 23.3 DYADIC INTERNATIONAL INC.
- 23.3.1 COMPANY OVERVIEW
- 23.3.2 BUSINESS OVERVIEW
- 23.3.3 PRODUCT OFFERINGS
- 23.4 AMANO ENZYME INC.
- 23.4.1 COMPANY OVERVIEW
- 23.4.2 BUSINESS OVERVIEW
- 23.4.3 PRODUCT OFFERINGS
- 23.5 BIOCATALYSTS
- 23.5.1 COMPANY OVERVIEW
- 23.5.2 BUSINESS OVERVIEW
- 23.5.3 PRODUCT OFFERINGS
- 23.6 NATURE BIOSCIENCE
- 23.6.1 COMPANY OVERVIEW
- 23.6.2 BUSINESS OVERVIEW
- 23.6.3 PRODUCT OFFERINGS
- 23.7 JOHNSON MATTHEY
- 23.7.1 COMPANY OVERVIEW
- 23.7.2 BUSINESS OVERVIEW
- 23.7.3 PRODUCT OFFERINGS
- 23.8 ADVANCED ENZYMES TECHNOLOGIES
- 23.8.1 COMPANY OVERVIEW
- 23.8.2 BUSINESS OVERVIEW
- 23.8.3 PRODUCT OFFERINGS
- 23.9 ZYMTRONIX, INC.
- 23.9.1 COMPANY OVERVIEW
- 23.9.2 PRODUCT OFFERINGS
- 23.10 NUTRITECH
- 23.10.1 COMPANY OVERVIEW
- 23.10.2 PRODUCT OFFERINGS
- 23.11 F. HOFFMANN-LA ROCHE LTD (ROCHE CUSTOMBIOTECH)
- 23.11.1 COMPANY OVERVIEW
- 23.11.2 BUSINESS OVERVIEW
- 23.11.3 PRODUCT OFFERINGS
- 23.12 AUMENZYMES
- 23.12.1 COMPANY OVERVIEW
- 23.12.2 PRODUCT OFFERINGS
- 23.13 SOUFFLET GROUP
- 23.13.1 COMPANY OVERVIEW
- 23.13.2 BUSINESS OVERVIEW
- 23.13.3 PRODUCT OFFERINGS
- 23.14 IOSYNTH
- 23.14.1 COMPANY OVERVIEW
- 23.14.2 BUSINESS OVERVIEW
- 23.14.3 PRODUCT OFFERINGS
24 REPORT SUMMARY
- 24.1 KEY TAKEAWAYS
- 24.2 STRATEGIC RECOMMENDATIONS
25 QUANTITATIVE SUMMARY
- 25.1 MARKET BY END-USER
- 25.1.1 PHARMACEUTICAL
- 25.1.2 FOOD & BEVERAGE
- 25.1.3 ANIMAL NUTRITION
- 25.1.4 HOUSEHOLD
- 25.1.5 OTHERS
- 25.2 MARKET BY TYPE
- 25.2.1 CARBOHYDRASES
- 25.2.2 PROTEASES
- 25.2.3 POLYMERASES & NUCLEASES
- 25.2.4 LIPASES
- 25.2.5 PHYTASES
- 25.2.6 OTHER
26 GEOGRAPHY
- 26.1 NORTH AMERICA
- 26.1.1 TYPE
- 26.1.2 END-USER
- 26.2 EUROPE
- 26.2.1 TYPE
- 26.2.2 END-USER
- 26.3 APAC
- 26.3.1 TYPE
- 26.3.2 END-USER
- 26.4 MIDDLE EAST & AFRICA
- 26.4.1 TYPE
- 26.4.2 END-USER
- 26.5 LATIN AMERICA
- 26.5.1 TYPE
- 26.5.2 END-USER
27 APPENDIX